New
HealthMore in Health→
MYC-Driven Breast Cancer Weakness Points to New Drug Strategy
Key Takeaways
- A Helsinki team found MYC-heavy breast cancer cells become metabolically constrained.
- The cells appeared dependent on glutamine and elevated mitochondrial activity.
- Two investigational drugs slowed tumor growth in mice, but no human testing has been reported.
DE
DT Editorial Team··via medicalxpress.com